Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker studyResearch in context
Summary: Background: Recurrence risk after curative surgery for colorectal liver metastases (CRLM) remains high, underlining the need to identify prognostic markers enabling more individualised treatment approaches. Methods: In the MIRACLE, a prospective, observational biomarker study, a total of 1...
Saved in:
| Main Authors: | Lissa Wullaert, Maurice P.H.M. Jansen, Jaco Kraan, Yannick M. Meyer, Kelly Voigt, Stavros Makrodimitris, Vanja de Weerd, Corine M. Beaufort, Mai Van, Maarten Vermaas, Eric J.T. Belt, Paul D. Gobardhan, Stefan Sleijfer, Henk M.W. Verheul, John W.M. Martens, Dirk J. Grünhagen, Saskia M. Wilting, Cornelis Verhoef, Ninos Ayez, Jan H. Wijsman, Arjen M. Rijken, Pascal Doornebosch, Joost van der Hoeven, Boris Galjart, Diederik J. Höppener, Peter M.H. Nierop, Eric P. van der Stok, Jean Helmijr, Lindsay Angus, Pauline A.J. Mendelaar, Manouk K. Bos, Elisabeth M. Jongbloed, Khrystany T. Isebia, Noortje Verschoor, Ronald van Marion, Peggy Atmodimedjo, Hendrikus J. Dubbink |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | EClinicalMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537025003384 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
by: David Sinclair Thomas Junior, et al.
Published: (2025-05-01) -
Circulating Tumour Cells and FOXP3 in Regulatory T-Cells as New Modalities in Cancer Diagnosis and Metastasis Location Prediction
by: Ikhwan Rinaldi
Published: (2024-01-01) -
Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana
by: Tanja Jesenko, et al.
Published: (2024-12-01) -
Intra‐individual variation of circulating tumour DNA in lung cancer patients
by: Johanne A. Hojbjerg, et al.
Published: (2019-10-01) -
Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma
by: Qi Zhang, et al.
Published: (2024-11-01)